Circulating Insulin-Like Growth Factor 1-Related Biomarkers and Risk of Lethal Prostate Cancer.
Chaoran MaYe WangKathryn M WilsonLorelei A MucciMeir J StampferMichael PollakKathryn L PenneyPublished in: JNCI cancer spectrum (2021)
Our study provides suggestive evidence that among men who later develop prostate cancer, higher plasma PAPP-A levels measured prior to diagnosis are associated with increased risk of lethal compared with indolent disease.